The study's findings provide reassurance to clinicians evaluating cardiovascular safety in RA treatment decisions, particularly in the context of real-world populations.
The study's findings provide reassurance to clinicians evaluating cardiovascular safety in RA treatment decisions, particularly in the context of real-world populations.
Researchers analyzed data using validated mental health measures and patient-designed questions to assess depression, anxiety, mental wellbeing, and healthcare behaviors.
Researchers analyzed data using validated mental health measures and patient-designed questions to assess depression, anxiety, mental wellbeing, and healthcare behaviors.
A multicenter retrospective cohort study from Germany provides new evidence supporting the use of biologic disease-modifying antirheumatic drugs as first-line therapy in patients with adult-onset Still’s disease.
A multicenter retrospective cohort study from Germany provides new evidence supporting the use of biologic disease-modifying antirheumatic drugs as first-line therapy in patients with adult-onset Still’s disease.
In this patient–control study spanning from 2009 to 2018, researchers assessed air pollutant exposure and its possible role in the development of rheumatoid arthritis.
In this patient–control study spanning from 2009 to 2018, researchers assessed air pollutant exposure and its possible role in the development of rheumatoid arthritis.
Posttraumatic osteoarthritis remains a significant long-term complication following knee injuries such as anterior cruciate ligament ruptures and meniscal tears.
Posttraumatic osteoarthritis remains a significant long-term complication following knee injuries such as anterior cruciate ligament ruptures and meniscal tears.
The findings support the long-term effectiveness of early treat-to-target strategies in managing both rheumatoid and undifferentiated arthritis, with sustained control of disease activity and preservation of physical function.
The findings support the long-term effectiveness of early treat-to-target strategies in managing both rheumatoid and undifferentiated arthritis, with sustained control of disease activity and preservation of physical function.
Dr Alfred Kim from Barnes Jewish Hospital and Washington University School of Medicine reviews the latest breakthroughs and coming advances in therapeutics for systemic lupus erythematosus.
Dr Alfred Kim from Barnes Jewish Hospital and Washington University School of Medicine reviews the latest breakthroughs and coming advances in therapeutics for systemic lupus erythematosus.